nach oben

American Journal of Clinical Dermatology

Erschienen in:

01.08.2015 | Review Article

Dermal Fillers: An Update

verfasst von: Annelyse Cristine Ballin, Fredric S. Brandt, Alex Cazzaniga

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Injection of dermal fillers is the second most frequent nonsurgical cosmetic procedure performed in the USA. Dermal fillers are an option in the treatment of volume deficiency, scars, and rhytides; facial sculpting; facial contouring; and augmentation of specific anatomical sites such as the lips. The number of injectable dermal fillers available on the market increases yearly. Dermatologists and cosmetic surgeons should regularly review treatment options to provide patients with safe and effective filler options. This paper extensively reviews the properties of the available fillers, such as their rheology, longevity, and adverse effects, and how these properties affect the choice of filler agent for a particular patient or a particular site. Also, trends in dermal filler injections are discussed.

American Society of Plastic Surgeons. 2013 cosmetic plastic surgery statistics report of the American Society of Plastic Surgeons. Available at: http://www.plasticsurgery.org/Documents/news-resources/statistics/2013-statistics/plastic-surgery-statistics-full-report-2013.pdf. Accessed 9 Feb 2015.

US Census Bureau. An aging nation: the older population in the United States. US Census Bureau. Issued May 2014. Available at: http://www.census.gov/prod/2014pubs/p25-1140.pdf. Accessed 9 Feb 2015.

Fitzgerald R, Graivier MH, et al. Update on facial aging. Aesthet Surg J. 2010;30:11S–24S.PubMedCrossRef

Brandt FS, Kaufman J, Green JB, Ballin AC, Cazzaniga A. Hyaluronic acid fillers. In: Nouri K, editor. Dermatologic surgery: step by step. Oxford: Wiley-Blackwell; 2012. p. 259–85.

Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: a focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Dermatol. 2008;7(3):209–20.PubMed

Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plastic Reconstr Surg. 2007;119:2219–27.CrossRef

Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29(6):573–87.PubMed

Kontis TC. Contemporary review of injectable facial fillers. JAMA Facial Plast Surg. 2013;15(1):58–64.PubMedCrossRef

Conejo-Mir JS, Sanz Guirado S, Angel Munoz M. Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg. 2006;32:1079–81.PubMed

10.

Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy DM. Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes. Plast Reconstr Surg. 2009;123:1842–63.PubMedCrossRef

11.

Lemperle G, Knapp TR, Sadick NS, Lemperle SM. ArteFill permanent injectable for soft tissue augmentation: I. Mechanism of action and injection techniques. Aesthetic Plast Surg. 2010;34(3):264–72.PubMedCentralPubMedCrossRef

12.

Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg. 2009;35(Suppl 2):1672–80.PubMedCrossRef

13.

Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013;12(6):295–316.

14.

Suneva Medical, Inc. Protocol for the post-approval study of Artefill for correction of nasolabial folds. Available at: https://clinicaltrials.gov/ct2/show/record/NCT00778531?term=artefill&rank=4. Accessed 10 Feb 2015.

15.

Karnik J, Baumann L, Bruce S, Callender V, Cohen S, Grimes P, Joseph J, Shamban A, Spencer J, Tedaldi R, Werschler WP, Smith SR. A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne scars. J Am Acad Dermatol. 2014;71(1):77–83.PubMedCrossRef

16.

Goldberg D, Guana A, Volk A, et al. Single-arm study for the characterization of human tissue response to injectable poly-l-lactic acid. Dermatol Surg. 2013;39:915–22.PubMedCrossRef

17.

Vleggaar D. Facial volumetric correction with injectable poly-l-lactic acid. Dermatol Surg. 2005;3:1511–7.CrossRef

18.

Brandt FS, Cazzaniga A, Baumann L, Fagien S, Glazer S, Kenkel JM, Lowe NJ, Monheit GD, Narins RS, Rendon MI, Rohrich RJ, Werschler WP. Investigator global evaluations of efficacy of injectable poly-l-lactic acid versus human collagen in the correction of nasolabial fold wrinkles. Aesthet Surg J. 2011;31(5):521–8.PubMedCrossRef

19.

Fitzgerald R, Vleggaar D. Facial volume restoration of the aging face with poly-l-lactic acid. Dermatol Ther. 2011;24:2–27.PubMedCrossRef

20.

Rossner F, Rossner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease of reported events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety Study. J Cosmet Dermatol. 2009;8(1):14–8.PubMedCrossRef

21.

Woerle B, Hanke CW, Sattler G. Poly-l-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol. 2004;3(4):385–9.PubMed

22.

Alessio R, Rzany B, Eve L, Grangier Y, Herranz P, Olivier-Masveyraud F, Vleggaar D. European expert recommendations on the use of injectable poly-l-lactic acid for facial rejuvenation. J Drugs Dermatol. 2014;13(9):1057–66.PubMed

23.

Palm MD, Goldman MP. Patient satisfaction and duration of effect with PLLA: a review of the literature. J Drugs Dermatol. 2009;8(10):s15–20.PubMed

24.

Smith S, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2):S112–21 (discussion S121).PubMed

25.

Moers-Carpi M, Vogt S, Santos BM, Planas J, Vallve SR, Howell DJ. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2):S144–51.PubMed

26.

Moers-Carpi MM, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial. Dermatol Surg. 2008;34(2):210–5.PubMedCrossRef

27.

Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J. 2010;30(2):235–8.PubMedCrossRef

28.

Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium hydroxylapatite (Radiesse) for correction of the mid-and lower face: consensus recommendations. Plast Reconstr Surg. 2007;120(6 Suppl):55S–66S.PubMedCrossRef

29.

Daley T, Damm DD, Haden JA, Kolodychak MT. Oral lesions associated with injected hydroxyapatite cosmetic filler. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(1):107–11.PubMedCrossRef

30.

Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008;34(Suppl 1):S9–15.PubMed

31.

Emer J, Sundaram H. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts (part 1 of 2). J Drugs Dermatol. 2013;12(12):1345–54.PubMed

32.

Sadick NS. A 52-week study of safety and efficacy of calcium hydroxylapatite for rejuvenation of the aging hand. J Drugs Dermatol. 2011;10(1):47–51.PubMed

33.

Marmur ES, Al Quran H, De Sa Earp AP, Yoo JY. A five-patient satisfaction pilot study of calcium hydroxylapatite injection for treatment of aging hands. Dermatol Surg. 2009;35(12):1978–84.PubMedCrossRef

34.

US Food and Drug Administration. Laviv cell therapy. Available at: http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/. Accessed 3 Feb 2015.

35.

Weiss RA. Autologous cell therapy: will it replace dermal fillers? Facial Plast Surg Clin N Am. 2013;21(2):299–304.CrossRef

36.

Smith SR, Munavalli G, Weiss R, Maslowski JM, Hennegan KP, Novak JM. A multicenter, double-blind, placebo controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles. Dermatol Surg. 2012;38(7 Pt 2):1234–43.PubMedCrossRef

37.

Weiss RA, Weiss MA, Beasley KL, Munavalli G. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, phase III clinical trial. Dermatol Surg. 2007;33(3):263–8.PubMed

38.

Fibrocell Science, Inc. Azficel-T (laViv) package insert. Fibrocell Science, Inc.; 2011. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM260489.pdf. Accessed 20 Dec 2014.

39.

Kablik J, Monheit GD, Yu L, et al. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35:S302–12.CrossRef

40.

Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg. 2010;36:1859–65.PubMedCrossRef

41.

Edsman K, Nord LI, Ohrlund A, Lärkner H, Kenne AH. Gel properties of hyaluronic acid dermal fillers. Dermatol Surg. 2012;38(7 Pt 2):1170–9.PubMedCrossRef

42.

Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther. 2008;10:35–42.PubMedCrossRef

43.

Flynn TC, Sarazin D, Bezzola A, Terrani C, Micheels P. Comparative histology of intradermal implantation of mono and biphasic hyaluronic acid fillers. Dermatol Surg. 2011;37(5):637–43.PubMedCrossRef

44.

Cohen JL, Dayan SH, Brandt FS, Nelson DB, Axford-Gatley RA, Theisen MJ, Narins RS. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg. 2013;39(2):205–31.PubMedCrossRef

45.

US Food and Drug Administration. Summary of safety and effectiveness data of Belotero. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf9/P090016b.pdf. Accessed 28 Feb 2015.

46.

Narins RS, Coleman WP III, Donofrio LM, et al. Improvement in nasolabial folds with a hyaluronic acid filler using a cohesive polydensified matrix technology: results from an 18-month open-label extension trial. Dermatol Surg. 2010;36(Suppl 3):1800–8.PubMedCrossRef

47.

Kühne U, Imhof M, Kirchmeir M, Howell DJ. Five-year retrospective review of safety, injected volumes, and longevity of the hyaluronic acid Belotero Basic for facial treatments in 317 patients. J Drugs Dermatol. 2012;11:1032–5.PubMed

48.

Downie JB, Grimes PE, Callender VD. A multicenter study of the safety and effectiveness of hyaluronic acid with a cohesive polydensified matrix for treatment of nasolabial folds in subjects with Fitzpatrick skin types IV, V, and VI. Plast Reconstr Surg. 2013;132(4 Suppl 2):41S–7S.PubMedCrossRef

49.

Goh AS, Kohn JC, Rootman DB, Lin JL, Goldberg RA. Hyaluronic acid gel distribution pattern in periocular area with high-resolution ultrasound imaging. Aesthet Surg J. 2014;34(4):510–5.PubMedCrossRef

50.

Prager W, Wissmueller E, Havermann I, et al. A prospective, split-face, randomized, comparative study of safety and 12-month longevity of three formulations of hyaluronic acid dermal filler for treatment of nasolabial folds. Dermatol Surg. 2012;38(7 Pt 2):1143–50.PubMedCrossRef

51.

Lorenc ZP, Fagien S, Flynn TC, Waldorf HA. Review of key Belotero Balance safety and efficacy trials. Plast Reconstr Surg. 2013;132(4 Suppl 2):33S–40S.PubMedCrossRef

52.

Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg. 2013;132(4 Suppl 2):5S–21S.PubMedCrossRef

53.

Lorenc ZR, Fagien S, Flynn TC, Waldorf HA. Clinical application and assessment of Belotero: a roundtable discussion. Plast Reconstr Surg. 2013;132(4S-2):69S–76S.PubMedCrossRef

54.

Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg. 2013;39(11):1602–12.PubMedCrossRef

55.

Carruthers J, Carruthers A, Tezel A, Kraemer J, Craik L. Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy. Dermatol Surg. 2010;36(Suppl 3):1886–92.PubMedCrossRef

56.

US Food and Drug Administration. Summary of safety and effectiveness data of Juvederm Voluma XC. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf11/P110033b.pdf. Accessed 10 Feb 2015.

57.

Raspaldo H. Volumizing effect of a new hyaluronic acid sub-dermal facial filler: a retrospective analysis based on 102 cases. J Cosmet Laser Ther. 2008;10(3):134–42.PubMedCrossRef

58.

Philipp-Dormston WG, Eccleston D, De Boulle K, Hilton S, van den Elzen H, Nathan M. A prospective, observational study of the volumizing effect of open-label aesthetic use of Juvéderm^® Voluma^® with lidocaine in mid-face area. J Cosmet Laser Ther. 2014;16(4):171–9.PubMedCrossRef

59.

US Food and Drug Administration. Summary of safety and effectiveness data of Restylane^® Silk injectable gel. http://www.accessdata.fda.gov/cdrh_docs/pdf4/P040024S072b.pdf. Accessed 2 Feb 2015.

60.

Micheels P, Sarazin D, Besse S, Sundaram H, Flynn TC. A blanching technique for intradermal injection of hyaluronic acid Belotero. Plast Reconstr Surg. 2013;132(4 Suppl 2):59S–68S.PubMedCrossRef

61.

Ballin AC, Cazzaniga A, Brandt FS. Long-term efficacy, safety and durability of Juvéderm^® XC. Clin Cosmet Investig Dermatol. 2013;6:183–9.PubMedCentralPubMed

62.

Levy PM, Boulle K, Raspaldo H. Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone. Dermatol Surg. 2009;35:332–7.PubMedCrossRef

63.

Weinkle SH, Bank DE, Boyd CM, Gold MH, Thomas JA, Murphy DK. A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvéderm injectable gel with and without lidocaine. J Cosmet Dermatol. 2009;8(3):205–10.PubMedCrossRef

64.

Marmur E, Green L, Busso M. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds. Dermatol Surg. 2010;36(3):309–15.PubMedCrossRef

65.

Tetzlaff JE. The pharmacology of local anesthetics. Anesthesiol Clin N Am. 2000;18(2):217–33.CrossRef

66.

Busso M, Voigts R. An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine. Dermatol Surg. 2008;34(Suppl 1):S16–24.PubMed

67.

Hesxel D, Soirefmann M, Porto MD, Siega C, Souza JS, Brum C. Double-blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds. Dermatol Surg. 2012;38(2):207–14.

Titel: Dermal Fillers: An Update
verfasst von: Annelyse Cristine Ballin
Fredric S. Brandt
Alex Cazzaniga
Publikationsdatum: 01.08.2015
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 4/2015
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-015-0135-7

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Dermal Fillers: An Update

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Comment on: Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation

Cellulite: An Evidence-Based Review

Poland’s Syndrome: A Concise Review of the Clinical Features Highlighting Associated Dermatologic Manifestations

Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria

Reply to Frane: Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation

Adverse Effects of Acne Medications: Recognition and Management

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie